Healio9d
FDA approves third Actemra biosimilar; second available in intravenous, subcutaneous forms
The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.
Healio10d
Use of IV tranexamic acid may not improve visual field clarity during hip arthroscopy
Results of a study showed administration of IV tranexamic acid within 15 minutes of incision did not significantly improve ...
Frontiers27d
Development and validation of an explainable machine learning prediction model of hemorrhagic transformation after intravenous thrombolysis in stroke
Methods: We retrospectively enrolled patients who received intravenous tissue plasminogen activator (IV-tPA) thrombolysis within 4.5 h after symptom onset to form the original modeling cohort. HT was ...